Americas Light/Laser Ablation Market
- Report Code: LI 1000
- Publish Date: Upcoming
The American Light/Laser Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing procedures through minimal invasive surgery was valued at $347 million in 2013 and is expected to reach $527 million by 2018. The Excimer Laser market is the largest segment of Light/Laser Ablation Market.
The Light/Laserablation devices consist of two types of lasers namely-cold lasers and excimer lasers. These are the most commonly used for ablation procedures in ophthalmology in vision correction and to a certain extent for epidermal treatment. It also shows considerable success in the ablation of cervix, uterus, varicose vein and prostate.
In terms of volume, the Americas contributed the largest volume of sales for the global Light/Laser ablation market.
Increasing regulatory scrutiny, strict reimbursement necessities, delays in regulatory approval and economic crisis have further resulted in drifting focus of market players from mature markets of Americas to emerging markets such as Latin America.
Currently, in the U.S., 40 million people are aged 65 and above and it is expected that by 2050 this number will rise to 89 million. Diseases such as cancer, cardiovascular disorders, gynecological, and orthopedic problems are on the rise. As the number of patient population will increase it will lead to increase in the procedural volume of minimally invasive surgeries, ultimately giving rise to increased demand for ablation devices. SEER estimated that in U.S. 1,596,670 cancer patients will be diagnosed in 2011, in addition coronary artery disease is considered as one of the major causes of death in the U.S. Due to huge obese population (~30% of U.S. population) and high diabetic patient pool, it is expected that incidences of cardiovascular related disorders will continue to grow in the future.
In the mature markets such as U.S. and Canada, a faster trend of replacement of older technologies (such as electrical, thermal & radiation) and quicker adoption of new and better ablation technologies (such as radio frequency, microwave and cryoablation) is observed. On the other hand, old technologies in ablation surgery still hold significant share in the Latin American market, however it is expected that in short term future new technologies will gain significant share in the market due to increased rate of physician education and availability of new ablation devices.
The report also provides an extensive competitive landscaping of companies operating in Light/Laser ablation market. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others.
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
The Market data enables you to customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Epidemiology Data
- Country specific Prevalence of cancer, cardiovascular disorders, gynecological, and orthopedic disorders.
- Country specific Patient pool of cancer, cardiovascular disorders, gynecological, and orthopedic disorders.
- Disease progression (Pattern analysis)
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology date
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Americas Thermal Ablation The American Thermal Ablation Market was pegged at $3097 million in 2013 and expected to be $5012 million by 2018. The main companies operating in thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others |
Upcoming |
|
|
Asia-Pacific Thermal Ablation The Asia-Pacific Thermal Ablation Market was pegged at $1533 million in 2013 and expected to be $2772 million by 2018. The main companies operating in Asia-Pacific Thermal Ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others. |
Upcoming |
|
|
European Thermal Ablation The European Thermal Ablation Market was pegged at $2132 million in 2013 and expected to be $3328 million by 2018. The main companies operating in European thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others. |
Upcoming |
